YB-209

N/A

Report date: 2025/06/11 11:17:12
NME

Base Information

Drug NameYB-209
Drug Alias NameFactor X Inhibitor (Jiuzhitang/Kunming Institute of Botany The Chinese Academy of Sciences/Yunnan Endian Technology)LFGLFG-53YB-209
ClassificationNatural product/ExtractSmall molecules > Carbohydrate > Oligosaccharide
Mechanisms of ActionCoagulation factor X inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesKunming Institute Of Botany, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesJiuzhitang Co Ltd
Inactive CompaniesEndian Science & Technology Development Of Yunnan Co LtdKunming Institute Of Botany, Chinese Academy Of Sciences
Active IndicationsThrombosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A